Biotech Analyst Olson, along with Key Opinion Leader, Dr. Kris Kowdley, discuss future treatments for Primary Biliary Cholangitis (PBC) (relevant for CBAY, ICPT, GNFT) on an Analyst/Industry conference call to be held on July 21 at 11 am. Webcast Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CBAY:
- Oppenheimer biotechnology analyst to hold an analyst/industry conference call
- CymaBay price target raised to $18 from $15 at BTIG
- Biotech Alert: Searches spiking for these stocks today
- CymaBay ‘competitive overhang’ now removed, says William Blair
- CymaBay files to sell 4.64M shares of common stock
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue